POU SHENG INT'L (03813) spent HK$42,300 to repurchase 90,000 shares on January 2nd.
Bao Sheng International (03813) announced that on January 2, 2026, the company repurchased 90,000 shares for a total of 42,300 Hong Kong dollars, at a repurchase price of 0.47 Hong Kong dollars per share.
POU SHENG INT'L (03813) announced on January 2, 2026 that the company will repurchase 90,000 shares at a cost of HKD 42,300, with a repurchase price of HKD 0.47 per share.
Related Articles
CSPC PHARMA (01093): Nintedanib Ethanesulfonate Inhalation Powder Aerosol Approved for Clinical Trials in China.
"A+H" stock craze continues! In December, a total of 27 A-share listed companies are planning to go public in Hong Kong, with CPO leader Suzhou TFC Optical Communication among them.
REDCO HEALTHY (02370): There is currently no information available on how the pledged shares will be handled in the event of the forced execution by the administrator.
CSPC PHARMA (01093): Nintedanib Ethanesulfonate Inhalation Powder Aerosol Approved for Clinical Trials in China.
"A+H" stock craze continues! In December, a total of 27 A-share listed companies are planning to go public in Hong Kong, with CPO leader Suzhou TFC Optical Communication among them.
REDCO HEALTHY (02370): There is currently no information available on how the pledged shares will be handled in the event of the forced execution by the administrator.
